Injective launched its Vulcan mainnet upgrade on June 9, aiming to improve perpetuals, stablecoins, and tokenization features. Following the announcement, INJ's price dropped 2.01% on the day and fell further by 7.14%, reflecting a typical "sell the news" reaction. Despite this short-term dip, technical analysis shows a potential bullish recovery, with key support levels between $3.72 and $5.04 and possible targets above $7.34. However, the overall longer-term trend remains bearish, and investors should remain cautious amid broader market weakness.
Coinbase has launched its x402 payment protocol on the Injective blockchain, allowing AI agents to independently pay for on-chain services without human intervention. The protocol automates payment flows for AI software, addressing the challenge of m...
Cryptocurrency prices are fluctuating with Bitcoin at $63,014 and Ethereum at $1,676.48, showing moderate gains. Several altcoins such as BEAT and DEXE have experienced significant increases, with BEAT up nearly 72% and DEXE up over 15%. These moveme...
